Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Jun;74(6):749–751. doi: 10.1136/jnnp.74.6.749

Association of neprilysin polymorphism with cerebral amyloid angiopathy

M Yamada 1, N Sodeyama 1, Y Itoh 1, A Takahashi 1, E Otomo 1, M Matsushita 1, H Mizusawa 1
PMCID: PMC1738486  PMID: 12754344

Abstract

Objectives: The risk of sporadic cerebral amyloid angiopathy (CAA) may be associated with genetic polymorphisms of molecules related to anabolism or catabolism of amyloid ß protein (Aß). The authors investigated whether a polymorphism of the gene (NEP) coding for neprilysin, an enzyme catabolising Aß, is associated with CAA.

Methods: The study analysed the GT repeat polymorphism in the enhancer/promoter region of NEP and severity of CAA in 164 necropsied elderly Japanese subjects.

Results: The subjects had NEP polymorphisms with 19 to 23 GT repeats and were classified into nine genotypes. CAA severity was significantly higher in the subjects with up to 40 repeats in total than those with more than 40 repeats (p=0.005). There was a significant correlation between the number of the shorter alleles (19 or 20 repeats) and CAA severity (p=0.024). In addition, there was no interaction between the NEP polymorphism and apolipoprotein E genotype.

Conclusions: These results suggest the association between the NEP polymorphism and the risk of CAA. Further study using more samples from populations with different ethnic backgrounds is necessary.

Full Text

The Full Text of this article is available as a PDF (99.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama H., Kondo H., Ikeda K., Kato M., McGeer P. L. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res. 2001 Jun 1;902(2):277–281. doi: 10.1016/s0006-8993(01)02390-3. [DOI] [PubMed] [Google Scholar]
  2. Calhoun M. E., Burgermeister P., Phinney A. L., Stalder M., Tolnay M., Wiederhold K. H., Abramowski D., Sturchler-Pierrat C., Sommer B., Staufenbiel M. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14088–14093. doi: 10.1073/pnas.96.24.14088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Comings D. E., Dietz G., Johnson J. P., MacMurray J. P. Association of the enkephalinase gene with low amplitude P300 waves. Neuroreport. 1999 Aug 2;10(11):2283–2285. doi: 10.1097/00001756-199908020-00011. [DOI] [PubMed] [Google Scholar]
  4. Greenberg S. M., Rebeck G. W., Vonsattel J. P., Gomez-Isla T., Hyman B. T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995 Aug;38(2):254–259. doi: 10.1002/ana.410380219. [DOI] [PubMed] [Google Scholar]
  5. Haouas H., Morello D., Lavenu A., Billard M., Jasmin C., Boucheix C. Characterization of the 5' region of the CD10/neutral endopeptidase 24.11 gene. Biochem Biophys Res Commun. 1995 Feb 27;207(3):933–942. doi: 10.1006/bbrc.1995.1275. [DOI] [PubMed] [Google Scholar]
  6. Ishimaru F., Shipp M. A. Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements. Blood. 1995 Jun 1;85(11):3199–3207. [PubMed] [Google Scholar]
  7. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N. P., Gerard C., Hama E., Lee H. J., Saido T. C. Metabolic regulation of brain Abeta by neprilysin. Science. 2001 May 25;292(5521):1550–1552. doi: 10.1126/science.1059946. [DOI] [PubMed] [Google Scholar]
  8. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H. J., Hama E., Sekine-Aizawa Y. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med. 2000 Feb;6(2):143–150. doi: 10.1038/72237. [DOI] [PubMed] [Google Scholar]
  9. Li C., Booze R. M., Hersh L. B. Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J Biol Chem. 1995 Mar 17;270(11):5723–5728. doi: 10.1074/jbc.270.11.5723. [DOI] [PubMed] [Google Scholar]
  10. Li C., Hersh L. B. Characterization of the promoter region of the rat neprilysin gene. Arch Biochem Biophys. 1998 Oct 1;358(1):189–195. doi: 10.1006/abbi.1998.0855. [DOI] [PubMed] [Google Scholar]
  11. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991 Apr;41(4):479–486. doi: 10.1212/wnl.41.4.479. [DOI] [PubMed] [Google Scholar]
  12. Nicoll J. A., Burnett C., Love S., Graham D. I., Dewar D., Ironside J. W., Stewart J., Vinters H. V. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol. 1997 Jun;41(6):716–721. doi: 10.1002/ana.410410607. [DOI] [PubMed] [Google Scholar]
  13. Oda Masaya, Morino Hiroyuki, Maruyama Hirofumi, Terasawa Hideo, Izumi Yuishin, Torii Tsuyoshi, Sasaki Ken, Nakamura Shigenobu, Kawakami Hideshi. Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease. Neurosci Lett. 2002 Mar 1;320(1-2):105–107. doi: 10.1016/s0304-3940(02)00057-5. [DOI] [PubMed] [Google Scholar]
  14. Premkumar D. R., Cohen D. L., Hedera P., Friedland R. P., Kalaria R. N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 1996 Jun;148(6):2083–2095. [PMC free article] [PubMed] [Google Scholar]
  15. Shinkai Y., Yoshimura M., Ito Y., Odaka A., Suzuki N., Yanagisawa K., Ihara Y. Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol. 1995 Sep;38(3):421–428. doi: 10.1002/ana.410380312. [DOI] [PubMed] [Google Scholar]
  16. Sodeyama N., Mizusawa H., Yamada M., Itoh Y., Otomo E., Matsushita M. Lack of association of neprilysin polymorphism with Alzheimer's disease and Alzheimer's disease-type neuropathological changes. J Neurol Neurosurg Psychiatry. 2001 Dec;71(6):817–818. doi: 10.1136/jnnp.71.6.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Takaki Y., Iwata N., Tsubuki S., Taniguchi S., Toyoshima S., Lu B., Gerard N. P., Gerard C., Lee H. J., Shirotani K. Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain. J Biochem. 2000 Dec;128(6):897–902. doi: 10.1093/oxfordjournals.jbchem.a022839. [DOI] [PubMed] [Google Scholar]
  18. Urmoneit B., Prikulis I., Wihl G., D'Urso D., Frank R., Heeren J., Beisiegel U., Prior R. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab Invest. 1997 Aug;77(2):157–166. [PubMed] [Google Scholar]
  19. Vinters H. V. Cerebral amyloid angiopathy. A critical review. Stroke. 1987 Mar-Apr;18(2):311–324. doi: 10.1161/01.str.18.2.311. [DOI] [PubMed] [Google Scholar]
  20. Weller R. O., Massey A., Newman T. A., Hutchings M., Kuo Y. M., Roher A. E. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol. 1998 Sep;153(3):725–733. doi: 10.1016/s0002-9440(10)65616-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology. 2000 Mar;20(1):8–22. doi: 10.1046/j.1440-1789.2000.00268.x. [DOI] [PubMed] [Google Scholar]
  22. Yamada M., Sodeyama N., Itoh Y., Otomo E., Matsushita M., Mizusawa H. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke. 2002 Apr;33(4):896–900. doi: 10.1161/01.str.0000013673.70986.ab. [DOI] [PubMed] [Google Scholar]
  23. Yamada M., Sodeyama N., Itoh Y., Suematsu N., Otomo E., Matsushita M., Mizusawa H. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann Neurol. 1998 Jul;44(1):129–131. doi: 10.1002/ana.410440120. [DOI] [PubMed] [Google Scholar]
  24. Yamada M., Sodeyama N., Itoh Y., Suematsu N., Otomo E., Matsushita M., Mizusawa H. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke. 1997 Nov;28(11):2219–2221. doi: 10.1161/01.str.28.11.2219. [DOI] [PubMed] [Google Scholar]
  25. Yamada M., Tsukagoshi H., Otomo E., Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol. 1987 Aug;234(6):371–376. doi: 10.1007/BF00314080. [DOI] [PubMed] [Google Scholar]
  26. Yasojima K., Akiyama H., McGeer E. G., McGeer P. L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett. 2001 Jan 12;297(2):97–100. doi: 10.1016/s0304-3940(00)01675-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES